Physician profile
Jasmine Sinha
NPI 1730506718
$81,792.97
in general payments reported to CMS, 2019-2025
15 companies · $14K in 2025
The $14K reported for 2025 was more than what 94% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $143 · 2021: $1,643 · 2022: $51K · 2023: $671 · 2024: $15K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Consulting Fee: $6,800 · Food and Beverage: $3,782 · Travel and Lodging: $3,674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,690.00 |
| Consulting Fee | $6,800.00 |
| Food and Beverage | $3,782.05 |
| Travel and Lodging | $3,674.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $75,891.15 | 2019-2025 | Wallflex Duodenal, Axios, General - Endochoice |
| Cook Incorporated | $2,790.00 | 2025 | Hemospray |
| Conmed Corporation | $1,280.11 | 2023-2025 | Conmed Biliary, Conmed Dilation, Conmed Generators |
| Cook Medical LLC | $613.68 | 2019-2025 | Hemospray, Echotip Insight, Oasis |
| Medtronic, INC. | $323.36 | 2022-2023 | Gi Genius |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $182.56 | 2021 | |
| Abbvie INC. | $143.45 | 2020 | |
| Apollo Endosurgery US INC | $136.25 | 2023 | Overstitch Endoscopic Suturing System |
| Pfizer INC. | $119.62 | 2019 | |
| Janssen Scientific Affairs, LLC | $111.35 | 2021 | |
| Endogastric Solutions, INC | $54.08 | 2021 | |
| Erbe USA INC | $50.22 | 2021 | |
| Mauna Kea Technologies, INC. | $37.17 | 2023 | |
| Olympus America INC. | $31.96 | 2025 | Gastrointestinal Videoscope |
| Janssen Biotech, INC. | $28.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.